CARLOMAGNO, Chiara
CARLOMAGNO, Chiara
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
2007 T., Suter; M., Procter; DJ Van, Veldhuisen; M., Muscholl; J., Bergh; Carlomagno, Chiara; T., Perren; R., Passalacqua; C., Bighin; J., Klijn; Ft, Ageev; E., Hiltre; J., Groetez; H., Iwata; M., Knap; M., Gnant; S., Muehlbauer; A., Spence; Rd, Gelber; MJ Piccart, Gebhart
Cancro del colon-retto
2011 Carlomagno, Chiara; DE PLACIDO, Sabino
Weekly docetaxel and capecitabine in the treatment of advanced gastric cancer: a phase II study
2006 M., Orditura; G., Aurilio; G., Galizia; Carlomagno, Chiara; E., Lieto; L., Vecchione; E., Martinelli; DE PLACIDO, Sabino; G., Catalano; F., Ciardiello; F., De Vita
Altri tumori gastrointestinali
2011 Tortora, Giampaolo; Palmieri, Giovannella; Carlomagno, Chiara
Prognostic significance of necrosis, elestosis, fibrosis and inflammatory cell reaction in operable breast cancer.
1995 Carlomagno, Chiara; Perrone, F.; Lauria, R.; DE LAURENTIIS, Michelino; Gallo, C.; Morabito, A.; Pettinato, Guido; Panico, L.; Bellelli, T.; Apicella, A.; Putrella, G.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience
2013 Moretto, Roberto; Raimondo, Lucia; DE STEFANO, Alfonso; Cella, CHIARA ALESSANDRA; Matano, E; DE PLACIDO, Sabino; Carlomagno, Chiara
Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study.
2006 Orditura, M; Martinelli, E; Galizia, G; Carlomagno, Chiara; Aurilio, G; Vecchione, L; Lieto, E; DE PLACIDO, Sabino; Catalano, G; Ciardiello, F; DE VITA, F.
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer
2012 DELLA VITTORIA SCARPATI, Giuseppina; Falcetta, Francesca; Carlomagno, Chiara; Ubezio, Paolo; Marchini, Sergio; DE STEFANO, Alfonso; Singh Vijay, Kumar; D’Incalci, Maurizio; DE PLACIDO, Sabino; Pepe, Stefano
Unusual case of exacerbation of sub-acute descending necrotizing mediastinitis
2013 Di Crescenzo, V; Laperuta, P; Napolitano, F; Carlomagno, Chiara; Danzi, Michele; Amato, B; Garzi, A; Vitale, M.
SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE
2012 Malapelle, Umberto; Bellevicine, Claudio; Salatiello, Maria; DE LUCA, Caterina; Rispo, Elisabetta; Riccio, Palmira; Sparano, Lucianna; DE STEFANO, Alfonso; Carlomagno, Chiara; Maiello, Franceso; Vita, Giulia; Nappi, Osar; Troncone, Giancarlo
Adjuvant chemoendocrine therapy for early breast cancer: is it worthwhile?
1995 Perrone, F.; DE PLACIDO, Sabino; Gallo, C.; Carlomagno, Chiara; Lauria, R.; Bianco, ANGELO RAFFAELE
Adjuvant treatment for locally advanced rectal cancer patients after pre-operative chemoradiotherapy: when, and for whom?
2014 DE STEFANO, Alfonso; Moretto, R; Bucci, Luigi; Pepe, S; Romano, Fj; Cella, Ca; Attademo, L; Rosanova, M; De Falco, S; Fiore, G; Raimondo, L; DE PLACIDO, Sabino; Carlomagno, Chiara
Diagnostic utility of BRAFV600E mutation testing in thyroid nodules in elderly patients
2013 Guerra, A; Di Crescenzo, V; Garzi, A; Carlomagno, Chiara; Pepe, S; Zeppa, P; Tonacchera, M; Vitale, M.
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients.
2013 Malapelle, Umberto; Bellevicine, Claudio; DE LUCA, Caterina; Salatiello, M; DE STEFANO, Alfonso; Rocco, D; de Rosa, N; Vitiello, F; Russo, S; Pepe, F; Iaccarino, A; Micheli, P; Illiano, A; Carlomagno, Chiara; Piantedosi, Fv; Troncone, Giancarlo
A phase II study of beweekly oxaliplatin plus infusional 5fluorouracil and folinic acid (FOLFOX4) as first-line treatment of advenced gastric cancer patients
2004 F., De Vita; M., Orditura; Matano, Elide; Bianco, Roberto; Carlomagno, Chiara; S., Infusino; Damiano, Vincenzo; E., Simeone; Mr, Diadema; E., Lieto; P., Castellano; S., Pepe; DE PLACIDO, Sabino; G., Galizia; F., Ciardiello; G., Catalano; Ar, Bianco
C-erbB2 overexpression decreases the benefit of adiuvant tamoxifen in early breast cancer without axillary lymph node metastases.
1996 Carlomagno, Chiara; Perrone, F.; Gallo, C.; DE LAURENTIIS, Michelino; Lauria, R.; Morabito, A.; Pettinato, G.; Bianco, A. R.; DE PLACIDO, Sabino
HER2 as predictive marker of resistance to endocrine treatment for advanced bresat cancer: a metanalysis of published studies
2002 DE LAURENTIIS, Michelino; Arpino, Grazia; E., Massarelli; A., Ruggiero; Carlomagno, Chiara; G., Tortora; F., Ciardiello; Ar, Bianco
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as initial treatment for metastatic colorectal cancer (TRIBE study): updated survival results and final molecular subgroups analyses.
2015 Fotios, Loupakis; Chiara, Cremolini; Carlotta, Antoniotti; Sara, Lonardi; Monica, Ronzoni; Alberto, Zaniboni; Giuseppe, Tonini; Lisa, Salvatore; Silvana, Chiara; Carlomagno, Chiara; Chiara, Banzi; Francesca, Negri; Lorenzo, Marcucci; Carlo, Barone; Gabriella, Fontanini; Nicla, Borrelli; Mirella, Giordano; Elisabetta, Macerola; Luca, Boni; Alfredo, Falcone
High-rsolution melting analysis (HRMA) for KRAS mutatiinal study in patients with metastatic colorectal cancer (mCRC pts)
2012 De Stefano, A; Malapelle, Umberto; Carlomagno, Chiara; Bianco, Roberto; Marciano, Roberta; Cimminiello, C; Colantuoni, M; DE PLACIDO, Sabino; Troncone, Giancarlo
Cancro del colon-retto
2007 Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial | 1.5 Abstract in rivista | 2007 | T., Suter; M., Procter; DJ Van, Veldhuisen; M., Muscholl; J., Bergh; Carlomagno, Chiara; T., Perren; R., Passalacqua; C., Bighin; J., Klijn; Ft, Ageev; E., Hiltre; J., Groetez; H., Iwata; M., Knap; M., Gnant; S., Muehlbauer; A., Spence; Rd, Gelber; MJ Piccart, Gebhart | |
| Cancro del colon-retto | 2.1 Contributo in volume (Capitolo o Saggio) | 2011 | Carlomagno, Chiara; DE PLACIDO, Sabino | |
| Weekly docetaxel and capecitabine in the treatment of advanced gastric cancer: a phase II study | 1.5 Abstract in rivista | 2006 | M., Orditura; G., Aurilio; G., Galizia; Carlomagno, Chiara; E., Lieto; L., Vecchione; E., Martinelli; DE PLACIDO, Sabino; G., Catalano; F., Ciardiello; F., De Vita | |
| Altri tumori gastrointestinali | 2.1 Contributo in volume (Capitolo o Saggio) | 2011 | Tortora, Giampaolo; Palmieri, Giovannella; Carlomagno, Chiara | |
| Prognostic significance of necrosis, elestosis, fibrosis and inflammatory cell reaction in operable breast cancer. | 1.1 Articolo in rivista | 1995 | Carlomagno, Chiara; Perrone, F.; Lauria, R.; DE LAURENTIIS, Michelino; Gallo, C.; Morabito, A.; Pettinato, Guido; Panico, L.; Bellelli, T.; Apicella, A.; Putrella, G.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience | 1.1 Articolo in rivista | 2013 | Moretto, Roberto; Raimondo, Lucia; DE STEFANO, Alfonso; Cella, CHIARA ALESSANDRA; Matano, E; DE PLACIDO, Sabino; Carlomagno, Chiara | |
| Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study. | 1.1 Articolo in rivista | 2006 | Orditura, M; Martinelli, E; Galizia, G; Carlomagno, Chiara; Aurilio, G; Vecchione, L; Lieto, E; DE PLACIDO, Sabino; Catalano, G; Ciardiello, F; DE VITA, F. | |
| A specific miRNA signature correlates with complete pathological response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer | 1.1 Articolo in rivista | 2012 | DELLA VITTORIA SCARPATI, Giuseppina; Falcetta, Francesca; Carlomagno, Chiara; Ubezio, Paolo; Marchini, Sergio; DE STEFANO, Alfonso; Singh Vijay, Kumar; D’Incalci, Maurizio; DE PLACIDO, Sabino; Pepe, Stefano | |
| Unusual case of exacerbation of sub-acute descending necrotizing mediastinitis | 1.1 Articolo in rivista | 2013 | Di Crescenzo, V; Laperuta, P; Napolitano, F; Carlomagno, Chiara; Danzi, Michele; Amato, B; Garzi, A; Vitale, M. | |
| SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE | 1.1 Articolo in rivista | 2012 | Malapelle, Umberto; Bellevicine, Claudio; Salatiello, Maria; DE LUCA, Caterina; Rispo, Elisabetta; Riccio, Palmira; Sparano, Lucianna; DE STEFANO, Alfonso; Carlomagno, Chiara; Maiello, Franceso; Vita, Giulia; Nappi, Osar; Troncone, Giancarlo | |
| Adjuvant chemoendocrine therapy for early breast cancer: is it worthwhile? | 1.1 Articolo in rivista | 1995 | Perrone, F.; DE PLACIDO, Sabino; Gallo, C.; Carlomagno, Chiara; Lauria, R.; Bianco, ANGELO RAFFAELE | |
| Adjuvant treatment for locally advanced rectal cancer patients after pre-operative chemoradiotherapy: when, and for whom? | 1.1 Articolo in rivista | 2014 | DE STEFANO, Alfonso; Moretto, R; Bucci, Luigi; Pepe, S; Romano, Fj; Cella, Ca; Attademo, L; Rosanova, M; De Falco, S; Fiore, G; Raimondo, L; DE PLACIDO, Sabino; Carlomagno, Chiara | |
| Diagnostic utility of BRAFV600E mutation testing in thyroid nodules in elderly patients | 1.1 Articolo in rivista | 2013 | Guerra, A; Di Crescenzo, V; Garzi, A; Carlomagno, Chiara; Pepe, S; Zeppa, P; Tonacchera, M; Vitale, M. | |
| EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. | 1.1 Articolo in rivista | 2013 | Malapelle, Umberto; Bellevicine, Claudio; DE LUCA, Caterina; Salatiello, M; DE STEFANO, Alfonso; Rocco, D; de Rosa, N; Vitiello, F; Russo, S; Pepe, F; Iaccarino, A; Micheli, P; Illiano, A; Carlomagno, Chiara; Piantedosi, Fv; Troncone, Giancarlo | |
| A phase II study of beweekly oxaliplatin plus infusional 5fluorouracil and folinic acid (FOLFOX4) as first-line treatment of advenced gastric cancer patients | 1.5 Abstract in rivista | 2004 | F., De Vita; M., Orditura; Matano, Elide; Bianco, Roberto; Carlomagno, Chiara; S., Infusino; Damiano, Vincenzo; E., Simeone; Mr, Diadema; E., Lieto; P., Castellano; S., Pepe; DE PLACIDO, Sabino; G., Galizia; F., Ciardiello; G., Catalano; Ar, Bianco | |
| C-erbB2 overexpression decreases the benefit of adiuvant tamoxifen in early breast cancer without axillary lymph node metastases. | 1.1 Articolo in rivista | 1996 | Carlomagno, Chiara; Perrone, F.; Gallo, C.; DE LAURENTIIS, Michelino; Lauria, R.; Morabito, A.; Pettinato, G.; Bianco, A. R.; DE PLACIDO, Sabino | |
| HER2 as predictive marker of resistance to endocrine treatment for advanced bresat cancer: a metanalysis of published studies | 1.5 Abstract in rivista | 2002 | DE LAURENTIIS, Michelino; Arpino, Grazia; E., Massarelli; A., Ruggiero; Carlomagno, Chiara; G., Tortora; F., Ciardiello; Ar, Bianco | |
| FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as initial treatment for metastatic colorectal cancer (TRIBE study): updated survival results and final molecular subgroups analyses. | 1.5 Abstract in rivista | 2015 | Fotios, Loupakis; Chiara, Cremolini; Carlotta, Antoniotti; Sara, Lonardi; Monica, Ronzoni; Alberto, Zaniboni; Giuseppe, Tonini; Lisa, Salvatore; Silvana, Chiara; Carlomagno, Chiara; Chiara, Banzi; Francesca, Negri; Lorenzo, Marcucci; Carlo, Barone; Gabriella, Fontanini; Nicla, Borrelli; Mirella, Giordano; Elisabetta, Macerola; Luca, Boni; Alfredo, Falcone | |
| High-rsolution melting analysis (HRMA) for KRAS mutatiinal study in patients with metastatic colorectal cancer (mCRC pts) | 1.5 Abstract in rivista | 2012 | De Stefano, A; Malapelle, Umberto; Carlomagno, Chiara; Bianco, Roberto; Marciano, Roberta; Cimminiello, C; Colantuoni, M; DE PLACIDO, Sabino; Troncone, Giancarlo | |
| Cancro del colon-retto | 2.1 Contributo in volume (Capitolo o Saggio) | 2007 | Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar |